Evidence map›Paper›PMID 42353184›Full record

ArticleInternational journal of molecular sciences2026

Phage-Encoded Depolymerase DepKP144 with Therapeutic Potential Against Both K1- and K2-Type

Ekaterina A Kondakova, Natalia N Golosova, Bogdana I Kravchuk, Yana A Khlusevich, Vyacheslav I Yakubovskij, Yuliya N Kozlova, Svetlana A Grishkova, Nina V Tikunova, Andrey L Matveev

Abstract read
In one paragraph

Article in International journal of molecular sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Ekaterina A KondakovaInstitute of Chemical Biology and Fundamental Medicine Siberian Branch of Russian Academy of Sciences, 630090 Novosibirsk, Russia.
Natalia N GolosovaInstitute of Chemical Biology and Fundamental Medicine Siberian Branch of Russian Academy of Sciences, 630090 Novosibirsk, Russia.
Bogdana I KravchukInstitute of Chemical Biology and Fundamental Medicine Siberian Branch of Russian Academy of Sciences, 630090 Novosibirsk, Russia.ORCID 0000-0003-2066-8975
Yana A KhlusevichInstitute of Chemical Biology and Fundamental Medicine Siberian Branch of Russian Academy of Sciences, 630090 Novosibirsk, Russia.ORCID 0000-0002-1413-5876
Vyacheslav I YakubovskijInstitute of Chemical Biology and Fundamental Medicine Siberian Branch of Russian Academy of Sciences, 630090 Novosibirsk, Russia.
Yuliya N KozlovaInstitute of Chemical Biology and Fundamental Medicine Siberian Branch of Russian Academy of Sciences, 630090 Novosibirsk, Russia.
Svetlana A GrishkovaInstitute of Chemical Biology and Fundamental Medicine Siberian Branch of Russian Academy of Sciences, 630090 Novosibirsk, Russia.
Nina V TikunovaInstitute of Chemical Biology and Fundamental Medicine Siberian Branch of Russian Academy of Sciences, 630090 Novosibirsk, Russia.
Andrey L MatveevInstitute of Chemical Biology and Fundamental Medicine Siberian Branch of Russian Academy of Sciences, 630090 Novosibirsk, Russia.ORCID 0000-0002-6884-6104

Funding

Russian Science Foundation 23-74-10105The Ministry of Education and Science of the Russian Federation 125041005114-8
6 · The paper itself

Abstract

Multidrug resistance (MDR) is a global problem for the healthcare system, complicating the therapy of bacterial infections. It is noted that patients infected with MDR strains often require prolonged hospitalization, have a high risk of mortality, and remain vulnerable to reinfection after recovery. In this study, recombinant phage-encoded depolymerase DepKP144 was produced using the

Indexed as

Anti-Bacterial AgentsBacteriophagesKlebsiella InfectionsKlebsiella pneumoniaeViral ProteinsAnimalsBiofilmsDrug Resistance, Multiple, BacterialHumansMiceAnti-Bacterial AgentsViral Proteinsantibacterialsbiofilm degradationcapsular polysaccharidedepolymeraseK1-typeK2-typeKlebsiella pneumoniaeK. pneumoniaemulti drug resistance

Identifiers

PMID42353184
PMCPMC13300036

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.